Teglicar
98%
- Product Code: 109786
CAS:
250694-07-6
| Molecular Weight: | 399.611 g./mol | Molecular Formula: | C₂₂H₄₅N₃O₃ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C, airtight, dry |
Product Description:
Teglicar is primarily used in the field of metabolic research, particularly in the study of diabetes and obesity. It functions as an inhibitor of carnitine palmitoyltransferase 1 (CPT1), an enzyme crucial for fatty acid oxidation. By inhibiting CPT1, Teglicar helps researchers understand the metabolic pathways involved in lipid metabolism and energy homeostasis. This makes it a valuable tool in exploring potential therapeutic strategies for metabolic disorders, such as improving insulin sensitivity or reducing lipid accumulation in tissues. Additionally, Teglicar is utilized in preclinical studies to investigate its effects on liver function and its potential role in managing non-alcoholic fatty liver disease (NAFLD). Its application extends to studying the interplay between lipid metabolism and other physiological processes, offering insights into the development of novel treatments for metabolic diseases.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | $7,973.57 |
+
-
|
Teglicar
Teglicar is primarily used in the field of metabolic research, particularly in the study of diabetes and obesity. It functions as an inhibitor of carnitine palmitoyltransferase 1 (CPT1), an enzyme crucial for fatty acid oxidation. By inhibiting CPT1, Teglicar helps researchers understand the metabolic pathways involved in lipid metabolism and energy homeostasis. This makes it a valuable tool in exploring potential therapeutic strategies for metabolic disorders, such as improving insulin sensitivity or reducing lipid accumulation in tissues. Additionally, Teglicar is utilized in preclinical studies to investigate its effects on liver function and its potential role in managing non-alcoholic fatty liver disease (NAFLD). Its application extends to studying the interplay between lipid metabolism and other physiological processes, offering insights into the development of novel treatments for metabolic diseases.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :